Loading…

Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products

We studied platelet recovery in relation to graft content in CFUs and CD34+ cells in 31 patients with multiple myeloma (21) or non-Hodgkin lymphoma (10) receiving marrow-ablative therapy followed by autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products. Twe...

Full description

Saved in:
Bibliographic Details
Published in:Hematology and cell therapy 1997-12, Vol.39 (6), p.317-325
Main Authors: Hermouet, S, Niaussat, A E, Briec, A, Pineau, D, Robillard, N, Bataille, R, Milpied, N, Harousseau, J L, Mahé, B
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c296t-7112aa8827483e38e1d340caa2acba17f0a200327e738d46f713559344e9bb5d3
cites
container_end_page 325
container_issue 6
container_start_page 317
container_title Hematology and cell therapy
container_volume 39
creator Hermouet, S
Niaussat, A E
Briec, A
Pineau, D
Robillard, N
Bataille, R
Milpied, N
Harousseau, J L
Mahé, B
description We studied platelet recovery in relation to graft content in CFUs and CD34+ cells in 31 patients with multiple myeloma (21) or non-Hodgkin lymphoma (10) receiving marrow-ablative therapy followed by autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products. Twelve patients had prolonged post-transplantation thrombopenia (> or = 14 days): their graft contents in CD34+ cells, CFU-GM and BFU-E were significantly inferior to those of patients with rapid platelet recovery. Although numbers of infused CD34+ cells and CFU-GM or BFU-E were well correlated, the graft content in CD34+ cells was the only parameter predictive of platelet recovery (r = -0.38, p = 0.04), with a threshold of 2.5 x 10(6) CD34+ cells/kg. However, because rapid platelet reconstitution was obtained for 4 of 16 patients re-infused with < 2.5 x 10(6) CD34+ cells/kg, we investigated whether the graft CFU-MK content might be a better predictor of platelet reconstitution than the CD34+ cell content. Eighteen CD34 grafts were studied for CFU-MK content: CD34 and CFU-MK contents were weakly correlated (r = 0.52, p = 0.03), but there was no correlation between numbers of infused CFU-MK and time to platelet recovery. We conclude that, for autologous CD34 grafts, CFU-MK assays, like CFU-GM or BFU-E assays, cannot be used to predict platelet recovery. A CD34+ cell content > or = 2.5 x 10(6)/kg remains the only reliable indicator of the platelet reconstitution capacity of a CD34 graft.
doi_str_mv 10.1007/s00282-997-0317-8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79561496</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79561496</sourcerecordid><originalsourceid>FETCH-LOGICAL-c296t-7112aa8827483e38e1d340caa2acba17f0a200327e738d46f713559344e9bb5d3</originalsourceid><addsrcrecordid>eNo9kM1u1TAQha2KqpTSB2CB5BUbZPBPEtvL6pYWpEosWtbWJJlQgxMH2wHdrvvgTXSvWM1odM6ZmY-Qd4J_Epzrz5lzaSSzVjOuhGbmhJwLqS0zNbevtr6xTEnTvCZvcv7FObdC2DNyZiurjRXn5PlqgrDPPtM40DlAwYCFJuziX0x7CkPBRGEpMcSfccm0JJjyqpsKFB8n-s-XR3rLdvc3dIytD_4Je7q7VtVH2mEImc5L8oNfh0OKIw24_Ib5ERNuK-cU-6Ur-S05HSBkvDzWC_Lj5svD7iu7-377bXd1xzppm8K0EBLAGKkro1AZFL2qeAcgoWtB6IGD5FxJjVqZvmoGLVRdW1VVaNu27tUF-XDIXRf_WTAXN_q8nQkTrs85betGVLZZheIg7FLMOeHg5uRHSHsnuNvIuwN5t5J3G3lnVs_7Y_jSjtj_dxxRqxcps4DE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79561496</pqid></control><display><type>article</type><title>Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products</title><source>Alma/SFX Local Collection</source><creator>Hermouet, S ; Niaussat, A E ; Briec, A ; Pineau, D ; Robillard, N ; Bataille, R ; Milpied, N ; Harousseau, J L ; Mahé, B</creator><creatorcontrib>Hermouet, S ; Niaussat, A E ; Briec, A ; Pineau, D ; Robillard, N ; Bataille, R ; Milpied, N ; Harousseau, J L ; Mahé, B</creatorcontrib><description>We studied platelet recovery in relation to graft content in CFUs and CD34+ cells in 31 patients with multiple myeloma (21) or non-Hodgkin lymphoma (10) receiving marrow-ablative therapy followed by autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products. Twelve patients had prolonged post-transplantation thrombopenia (&gt; or = 14 days): their graft contents in CD34+ cells, CFU-GM and BFU-E were significantly inferior to those of patients with rapid platelet recovery. Although numbers of infused CD34+ cells and CFU-GM or BFU-E were well correlated, the graft content in CD34+ cells was the only parameter predictive of platelet recovery (r = -0.38, p = 0.04), with a threshold of 2.5 x 10(6) CD34+ cells/kg. However, because rapid platelet reconstitution was obtained for 4 of 16 patients re-infused with &lt; 2.5 x 10(6) CD34+ cells/kg, we investigated whether the graft CFU-MK content might be a better predictor of platelet reconstitution than the CD34+ cell content. Eighteen CD34 grafts were studied for CFU-MK content: CD34 and CFU-MK contents were weakly correlated (r = 0.52, p = 0.03), but there was no correlation between numbers of infused CFU-MK and time to platelet recovery. We conclude that, for autologous CD34 grafts, CFU-MK assays, like CFU-GM or BFU-E assays, cannot be used to predict platelet recovery. A CD34+ cell content &gt; or = 2.5 x 10(6)/kg remains the only reliable indicator of the platelet reconstitution capacity of a CD34 graft.</description><identifier>ISSN: 1269-3286</identifier><identifier>EISSN: 1279-8509</identifier><identifier>DOI: 10.1007/s00282-997-0317-8</identifier><identifier>PMID: 9497891</identifier><language>eng</language><publisher>France</publisher><subject>Adult ; Aged ; Antigens, CD34 - analysis ; Blood Cell Count ; Blood Platelets - cytology ; Blood Transfusion, Autologous ; Colony-Forming Units Assay ; Erythroid Precursor Cells - cytology ; Female ; Granulocyte Colony-Stimulating Factor - pharmacology ; Hematopoietic Stem Cell Mobilization ; Hematopoietic Stem Cell Transplantation ; Hematopoietic Stem Cells - chemistry ; Hematopoietic Stem Cells - immunology ; Humans ; Leukapheresis ; Lymphoma, Follicular - blood ; Male ; Middle Aged ; Multiple Myeloma - blood ; Neutrophils - cytology ; Thrombocytopenia - blood ; Thrombocytopenia - etiology ; Time Factors</subject><ispartof>Hematology and cell therapy, 1997-12, Vol.39 (6), p.317-325</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c296t-7112aa8827483e38e1d340caa2acba17f0a200327e738d46f713559344e9bb5d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9497891$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hermouet, S</creatorcontrib><creatorcontrib>Niaussat, A E</creatorcontrib><creatorcontrib>Briec, A</creatorcontrib><creatorcontrib>Pineau, D</creatorcontrib><creatorcontrib>Robillard, N</creatorcontrib><creatorcontrib>Bataille, R</creatorcontrib><creatorcontrib>Milpied, N</creatorcontrib><creatorcontrib>Harousseau, J L</creatorcontrib><creatorcontrib>Mahé, B</creatorcontrib><title>Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products</title><title>Hematology and cell therapy</title><addtitle>Hematol Cell Ther</addtitle><description>We studied platelet recovery in relation to graft content in CFUs and CD34+ cells in 31 patients with multiple myeloma (21) or non-Hodgkin lymphoma (10) receiving marrow-ablative therapy followed by autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products. Twelve patients had prolonged post-transplantation thrombopenia (&gt; or = 14 days): their graft contents in CD34+ cells, CFU-GM and BFU-E were significantly inferior to those of patients with rapid platelet recovery. Although numbers of infused CD34+ cells and CFU-GM or BFU-E were well correlated, the graft content in CD34+ cells was the only parameter predictive of platelet recovery (r = -0.38, p = 0.04), with a threshold of 2.5 x 10(6) CD34+ cells/kg. However, because rapid platelet reconstitution was obtained for 4 of 16 patients re-infused with &lt; 2.5 x 10(6) CD34+ cells/kg, we investigated whether the graft CFU-MK content might be a better predictor of platelet reconstitution than the CD34+ cell content. Eighteen CD34 grafts were studied for CFU-MK content: CD34 and CFU-MK contents were weakly correlated (r = 0.52, p = 0.03), but there was no correlation between numbers of infused CFU-MK and time to platelet recovery. We conclude that, for autologous CD34 grafts, CFU-MK assays, like CFU-GM or BFU-E assays, cannot be used to predict platelet recovery. A CD34+ cell content &gt; or = 2.5 x 10(6)/kg remains the only reliable indicator of the platelet reconstitution capacity of a CD34 graft.</description><subject>Adult</subject><subject>Aged</subject><subject>Antigens, CD34 - analysis</subject><subject>Blood Cell Count</subject><subject>Blood Platelets - cytology</subject><subject>Blood Transfusion, Autologous</subject><subject>Colony-Forming Units Assay</subject><subject>Erythroid Precursor Cells - cytology</subject><subject>Female</subject><subject>Granulocyte Colony-Stimulating Factor - pharmacology</subject><subject>Hematopoietic Stem Cell Mobilization</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Hematopoietic Stem Cells - chemistry</subject><subject>Hematopoietic Stem Cells - immunology</subject><subject>Humans</subject><subject>Leukapheresis</subject><subject>Lymphoma, Follicular - blood</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multiple Myeloma - blood</subject><subject>Neutrophils - cytology</subject><subject>Thrombocytopenia - blood</subject><subject>Thrombocytopenia - etiology</subject><subject>Time Factors</subject><issn>1269-3286</issn><issn>1279-8509</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNo9kM1u1TAQha2KqpTSB2CB5BUbZPBPEtvL6pYWpEosWtbWJJlQgxMH2wHdrvvgTXSvWM1odM6ZmY-Qd4J_Epzrz5lzaSSzVjOuhGbmhJwLqS0zNbevtr6xTEnTvCZvcv7FObdC2DNyZiurjRXn5PlqgrDPPtM40DlAwYCFJuziX0x7CkPBRGEpMcSfccm0JJjyqpsKFB8n-s-XR3rLdvc3dIytD_4Je7q7VtVH2mEImc5L8oNfh0OKIw24_Ib5ERNuK-cU-6Ur-S05HSBkvDzWC_Lj5svD7iu7-377bXd1xzppm8K0EBLAGKkro1AZFL2qeAcgoWtB6IGD5FxJjVqZvmoGLVRdW1VVaNu27tUF-XDIXRf_WTAXN_q8nQkTrs85betGVLZZheIg7FLMOeHg5uRHSHsnuNvIuwN5t5J3G3lnVs_7Y_jSjtj_dxxRqxcps4DE</recordid><startdate>199712</startdate><enddate>199712</enddate><creator>Hermouet, S</creator><creator>Niaussat, A E</creator><creator>Briec, A</creator><creator>Pineau, D</creator><creator>Robillard, N</creator><creator>Bataille, R</creator><creator>Milpied, N</creator><creator>Harousseau, J L</creator><creator>Mahé, B</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199712</creationdate><title>Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products</title><author>Hermouet, S ; Niaussat, A E ; Briec, A ; Pineau, D ; Robillard, N ; Bataille, R ; Milpied, N ; Harousseau, J L ; Mahé, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c296t-7112aa8827483e38e1d340caa2acba17f0a200327e738d46f713559344e9bb5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antigens, CD34 - analysis</topic><topic>Blood Cell Count</topic><topic>Blood Platelets - cytology</topic><topic>Blood Transfusion, Autologous</topic><topic>Colony-Forming Units Assay</topic><topic>Erythroid Precursor Cells - cytology</topic><topic>Female</topic><topic>Granulocyte Colony-Stimulating Factor - pharmacology</topic><topic>Hematopoietic Stem Cell Mobilization</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Hematopoietic Stem Cells - chemistry</topic><topic>Hematopoietic Stem Cells - immunology</topic><topic>Humans</topic><topic>Leukapheresis</topic><topic>Lymphoma, Follicular - blood</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multiple Myeloma - blood</topic><topic>Neutrophils - cytology</topic><topic>Thrombocytopenia - blood</topic><topic>Thrombocytopenia - etiology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hermouet, S</creatorcontrib><creatorcontrib>Niaussat, A E</creatorcontrib><creatorcontrib>Briec, A</creatorcontrib><creatorcontrib>Pineau, D</creatorcontrib><creatorcontrib>Robillard, N</creatorcontrib><creatorcontrib>Bataille, R</creatorcontrib><creatorcontrib>Milpied, N</creatorcontrib><creatorcontrib>Harousseau, J L</creatorcontrib><creatorcontrib>Mahé, B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hematology and cell therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hermouet, S</au><au>Niaussat, A E</au><au>Briec, A</au><au>Pineau, D</au><au>Robillard, N</au><au>Bataille, R</au><au>Milpied, N</au><au>Harousseau, J L</au><au>Mahé, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products</atitle><jtitle>Hematology and cell therapy</jtitle><addtitle>Hematol Cell Ther</addtitle><date>1997-12</date><risdate>1997</risdate><volume>39</volume><issue>6</issue><spage>317</spage><epage>325</epage><pages>317-325</pages><issn>1269-3286</issn><eissn>1279-8509</eissn><abstract>We studied platelet recovery in relation to graft content in CFUs and CD34+ cells in 31 patients with multiple myeloma (21) or non-Hodgkin lymphoma (10) receiving marrow-ablative therapy followed by autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products. Twelve patients had prolonged post-transplantation thrombopenia (&gt; or = 14 days): their graft contents in CD34+ cells, CFU-GM and BFU-E were significantly inferior to those of patients with rapid platelet recovery. Although numbers of infused CD34+ cells and CFU-GM or BFU-E were well correlated, the graft content in CD34+ cells was the only parameter predictive of platelet recovery (r = -0.38, p = 0.04), with a threshold of 2.5 x 10(6) CD34+ cells/kg. However, because rapid platelet reconstitution was obtained for 4 of 16 patients re-infused with &lt; 2.5 x 10(6) CD34+ cells/kg, we investigated whether the graft CFU-MK content might be a better predictor of platelet reconstitution than the CD34+ cell content. Eighteen CD34 grafts were studied for CFU-MK content: CD34 and CFU-MK contents were weakly correlated (r = 0.52, p = 0.03), but there was no correlation between numbers of infused CFU-MK and time to platelet recovery. We conclude that, for autologous CD34 grafts, CFU-MK assays, like CFU-GM or BFU-E assays, cannot be used to predict platelet recovery. A CD34+ cell content &gt; or = 2.5 x 10(6)/kg remains the only reliable indicator of the platelet reconstitution capacity of a CD34 graft.</abstract><cop>France</cop><pmid>9497891</pmid><doi>10.1007/s00282-997-0317-8</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1269-3286
ispartof Hematology and cell therapy, 1997-12, Vol.39 (6), p.317-325
issn 1269-3286
1279-8509
language eng
recordid cdi_proquest_miscellaneous_79561496
source Alma/SFX Local Collection
subjects Adult
Aged
Antigens, CD34 - analysis
Blood Cell Count
Blood Platelets - cytology
Blood Transfusion, Autologous
Colony-Forming Units Assay
Erythroid Precursor Cells - cytology
Female
Granulocyte Colony-Stimulating Factor - pharmacology
Hematopoietic Stem Cell Mobilization
Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cells - chemistry
Hematopoietic Stem Cells - immunology
Humans
Leukapheresis
Lymphoma, Follicular - blood
Male
Middle Aged
Multiple Myeloma - blood
Neutrophils - cytology
Thrombocytopenia - blood
Thrombocytopenia - etiology
Time Factors
title Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T15%3A08%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20platelet%20recovery%20after%20autologous%20transplantation%20with%20G-CSF%20mobilized%20CD34+%20cells%20purified%20from%20leukapheresis%20products&rft.jtitle=Hematology%20and%20cell%20therapy&rft.au=Hermouet,%20S&rft.date=1997-12&rft.volume=39&rft.issue=6&rft.spage=317&rft.epage=325&rft.pages=317-325&rft.issn=1269-3286&rft.eissn=1279-8509&rft_id=info:doi/10.1007/s00282-997-0317-8&rft_dat=%3Cproquest_cross%3E79561496%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c296t-7112aa8827483e38e1d340caa2acba17f0a200327e738d46f713559344e9bb5d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79561496&rft_id=info:pmid/9497891&rfr_iscdi=true